SAN MATEO, Calif., March 6, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that Remi Barbier, the Company's chairman, president and chief executive officer, will present at the Barclays Capital Global Healthcare Conference in Miami Beach, Florida on Wednesday, March 11th at 2:30 p.m. Eastern Time.

A live audio webcast of the presentation will be open to all on our web site, www.paintrials.com. A replay will also be available following the live event for approximately 14 days.

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In addition to REMOXY(r), a unique abuse-resistant controlled-release oxycodone, the Company has three drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia.

CONTACT:  Pain Therapeutics, Inc.
          Christi Waarich, Senior Manager of Investor Relations
          650-645-1924
          cwaarich@paintrials.com